Altamira Therapeutics (STU:2QA) Beginning Cash Position : €1.58 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Altamira Therapeutics Beginning Cash Position?

Altamira Therapeutics's Beginning Cash Position for the quarter that ended in Dec. 2023 was €1.58 Mil.

Altamira Therapeutics's quarterly Beginning Cash Position declined from Dec. 2022 (€0.38 Mil) to Jun. 2023 (€0.02 Mil) but then increased from Jun. 2023 (€0.02 Mil) to Dec. 2023 (€1.58 Mil).

Altamira Therapeutics's annual Beginning Cash Position declined from Dec. 2021 (€10.82 Mil) to Dec. 2022 (€1.00 Mil) and declined from Dec. 2022 (€1.00 Mil) to Dec. 2023 (€0.01 Mil).

Altamira Therapeutics Beginning Cash Position Historical Data

The historical data trend for Altamira Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altamira Therapeutics Beginning Cash Position Chart

Altamira Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

4.94

1.28

10.82

1.00

0.01

Altamira Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															8.14	0.96	0.38	0.02	1.58

Altamira Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Altamira Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Altamira Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Altamira Therapeutics (STU:2QA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Altamira Therapeutics Ltd (STU:2QA) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

CYTO:USA

Address

2 Church Street, Clarendon House, Hamilton, BMU, HM11

Website

https://www.altamiratherapeutics.com

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.

Altamira Therapeutics (STU:2QA) Headlines

No Headlines